☰

Galia Oberkovitz, Ph.D. - Publications

Affiliations: 
2010 Weizmann Institute of Science, Rehovot, Israel 
Area:
Molecular Biology, Medicine and Surgery
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Maryanovich M, Oberkovitz G, Niv H, Vorobiyov L, Zaltsman Y, Brenner O, Lapidot T, Jung S, Gross A. The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nature Cell Biology. 14: 535-41. PMID 22446738 DOI: 10.1038/Ncb2468  0.662
2009 Rotem-Dai N, Oberkovitz G, Abu-Ghanem S, Livneh E. PKCeta confers protection against apoptosis by inhibiting the pro-apoptotic JNK activity in MCF-7 cells. Experimental Cell Research. 315: 2616-23. PMID 19523467 DOI: 10.1016/j.yexcr.2009.06.004  0.502
2007 Abu-Ghanem S, Oberkovitz G, Benharroch D, Gopas J, Livneh E. PKCeta expression contributes to the resistance of Hodgkin's lymphoma cell lines to apoptosis. Cancer Biology & Therapy. 6: 1375-80. PMID 17786031  0.39
2007 Oberkovitz G, Regev L, Gross A. Nucleocytoplasmic shuttling of BID is involved in regulating its activities in the DNA-damage response. Cell Death and Differentiation. 14: 1628-34. PMID 17585339 DOI: 10.1038/Sj.Cdd.4402181  0.68
2005 Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L, Haimovich G, Lerenthal Y, Marcellus RC, Gross A. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell. 122: 593-603. PMID 16122426 DOI: 10.1016/J.Cell.2005.06.014  0.44
Show low-probability matches.